Lux Capital Management is a research-driven investment firm focused on de novo, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Our investment team has built over 20 companies from scratch. Lux’s investment strategy ensures our portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competitors.

The Lux team is recognized internationally as pioneers and thought-leaders in early stage venture capital. Our team has a successful track record of building, investing in, and adding highly strategic value to leading emerging technology companies started at more than 40 leading academic centers and government labs including MIT, Harvard, Cornell, University of Texas, UCLA, UC Berkeley, Columbia, Lawrence Livermore National Labs and Washington University. We’ve been invited by the President to the Oval Office, appear frequently on CNBC, CNN and Fox News, and are regularly cited in The Economist, Forbes, Business Week, Barron’s, and other leading financial and technology publications.

Lux has co-invested with leading private equity firms and multinational corporations. Some of Lux's investment partners include Goldman Sachs, Credit Suisse, Sequoia Capital, Venrock Associates, Polaris Venture Partners, Intel, Motorola, Genentech, and Medtronic.

Lux launched strategic portfolio companies in market research/business intelligence (Lux Research), media (Joint Venture with Forbes Magazine) and public policy (NanoBusiness Alliance). These entities provide us with multiple edges over other venture capital funds for sourcing deals, adding value to the entrepreneurs and companies we invest in, and exiting investments.